Javad Khodadadi
Overview
Explore the profile of Javad Khodadadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasiri M, Zarrin A, RoshankarRudsari S, Khodadadi J
IDCases
. 2023 May;
32:e01779.
PMID: 37187940
Background: Glanders is a rare disease that has been eradicated in many countries but may be difficult to diagnose due to its nonspecific symptoms. This disease, which can be highly...
2.
Khodadadi J, Dodangeh M, Nasiri M
IDCases
. 2023 Mar;
32:e01736.
PMID: 36938337
Introduction: Epididymo-orchitis (EO) is a disease of both the epididymis and ipsilateral testis. Brucellar epididymo-orchitis (BEO) is an uncommon localized infection of the testis and epididymis which occurs in about...
3.
Zamani M, Ghasemi A, Shamshirgaran M, Ahmadpour S, Hormati A, Khodadadi J, et al.
Avicenna J Med Biotechnol
. 2022 Sep;
14(3):233-238.
PMID: 36061129
Background: Evidence on seroconversion profile of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients is limited. We mainly aimed to evaluate seroconversion and persistence of virus-specific antibodies...
4.
Salehi M, Khalili H, Seifi A, Davoudi H, Alavi Darazam I, Jahangard-Rafsanjani Z, et al.
J Clin Pharm Ther
. 2022 Sep;
47(12):2140-2151.
PMID: 36054303
What Is Known And Objective: Although antibiotics are ineffective against viral infections, epidemiological studies have revealed that the COVID-19 pandemic resulted in the overuse of antibiotics and disruption of antimicrobial...
5.
Mobarak S, Salasi M, Hormati A, Khodadadi J, Ziaee M, Abedi F, et al.
J Antimicrob Chemother
. 2021 Dec;
77(3):758-766.
PMID: 34849957
Background: The combination of sofosbuvir and daclatasvir has shown preliminary efficacy for hospitalized patients with COVID-19 in four open-label studies with small sample sizes. This larger trial aimed to assess...
6.
Nasiri M, Khodadadi J, Hajrezaei Z, Bizhani N
Iran J Public Health
. 2021 Jun;
50(4):825-830.
PMID: 34183933
Background: We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease. Methods: In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their...
7.
Nasiri M, Khodadadi J, Molaei S
Int J Infect Dis
. 2021 May;
107:264-267.
PMID: 33940189
Background: Since the beginning of the Coronavirus disease 2019 (COVID-19) pandemic there have been contradictions and speculations about the relationship between vitamin D and COVID-19. Given that there is an...
8.
Solaymani-Dodaran M, Ghanei M, Bagheri M, Qazvini A, Vahedi E, Saadat S, et al.
Int Immunopharmacol
. 2021 Mar;
95:107522.
PMID: 33735712
Background: We examined the safety and efficacy of a treatment protocol containing Favipiravir for the treatment of SARS-CoV-2. Methods: We did a multicenter randomized open-labeled clinical trial on moderate to...
9.
Moghadam V, Momenimovahed Z, Ghorbani M, Khodadadi J
Braz J Anesthesiol
. 2021 Feb;
71(2):198.
PMID: 33619414
No abstract available.
10.
Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, et al.
BMC Infect Dis
. 2020 Sep;
20(1):646.
PMID: 32873235
Background: COVID-19 is known as a new viral infection. Viral-bacterial co-infections are one of the biggest medical concerns, resulting in increased mortality rates. To date, few studies have investigated bacterial...